Literature DB >> 19039303

PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline.

N Salem1, Y Kuang, F Wang, G T Maclennan, Z Lee.   

Abstract

AIM: This study was designed to investigate the performance of positron emission tomography (PET) imaging for hepatocellular carcinoma (HCC) on a hepatitis viral infection-induced woodchuck model using existing tracers such as 2-deoxy-2[(18)F]fluoro-D-glucose (2FDG), 6-deoxy-6[(18)F]fluoro-D-glucose (6FDG), [1(-11)C]acetate (acetate) and [N-methyl(-11)C]choline (choline).
METHODS: Fourteen woodchucks with HCC were imaged with different radiotracers: 13 (10 with HCC and 3 controls) with 2FDG; 4 (3 with HCC and 1 control) with 6FDG; 13 (10 with HCC and 3 controls) with acetate; 4 (2 with HCC and 2 controls) with choline. The woodchucks were euthanized after imaging experiments and liver tissues were harvested for histology, for enzymatic activities including hexokinase (HK), glucose-6-phosphatase, acetyl-CoA synthetase (ACAS) and choline kinase (CK), and for differential gene expressions between the HCCs and the surrounding hepatic tissues.
RESULTS: 2FDG detected 7/13 tumors with a tumor-to-liver uptake ratio (T/L) of 1.36+/-0.13. Five of these HCCs were moderately- or poorly-differentiated. The HK/glucose-6-phosphatase ratio was significantly higher in HCCs compared to the surrounding liver tissues (P=0.05). None of the HCCs imaged with 6FDG were detected by PET (T/L=1.01+/-0.11). Acetate detected 16/17 HCCs (T/L=2.02+/-0.7). ACAS activity was significantly higher in HCCs (P=0.01) and lipids-related genes were found up-regulated. Choline imaging detected all HCCs (T/L=1.63+/-0.34). CK activity was significantly higher in HCCs (P=0.001).
CONCLUSIONS: Well-differentiated and some moderately-differentiated HCCs do not uptake 2FDG more than the surrounding liver tissues, but display increased acetate uptake. There is no contrast between HCCs and the surrounding liver tissues on the 6FDG PET images. Despite elevated background signal from the liver, choline uptake seems to be detectable in the HCCs scanned in this study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19039303

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  26 in total

1.  The effect of fasting on PET Imaging of Hepatocellular Carcinoma.

Authors:  Nathan Tenley; David J Corn; Lewis Yuan; Zhenghong Lee
Journal:  J Cancer Ther       Date:  2013-04

2.  Attenuation of lung cancer stem cell tumorigenesis and metastasis by cisplatin.

Authors:  Shenxu Wang; Sai Ma; Xiujuan Li; Zengfu Xue; Xiaotian Zhang; Weiwei Fan; Yongzhan Nie; Kaichun Wu; Xiaoyuan Chen; Feng Cao
Journal:  Exp Lung Res       Date:  2014-08-25       Impact factor: 2.459

Review 3.  Metabolic positron emission tomography imaging in cancer detection and therapy response.

Authors:  Aizhi Zhu; Daniel Lee; Hyunsuk Shim
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

4.  Transcriptomics Associates Molecular Features with 18F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma.

Authors:  Sandi A Kwee; Maarit Tiirikainen; Miles M Sato; Jared D Acoba; Runmin Wei; Wei Jia; Loic Le Marchand; Linda L Wong
Journal:  Cancer Res       Date:  2019-02-13       Impact factor: 12.701

5.  Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma.

Authors:  William F Pritchard; David L Woods; Juan A Esparza-Trujillo; Matthew F Starost; Michal Mauda-Havakuk; Andrew S Mikhail; Ivane Bakhutashvili; Shelby Leonard; Elizabeth C Jones; Venkatesh Krishnasamy; John W Karanian; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2020-02-24       Impact factor: 3.464

6.  Validation of R-2-[18F]Fluoropropionic Acid as a Potential Tracer for PET Imaging of Liver Cancer.

Authors:  Zhanwen Zhang; Shaoyu Liu; Hui Ma; Dahong Nie; Fuhua Wen; Jing Zhao; Aixia Sun; Gongjun Yuan; Shu Su; Xianhong Xiang; Ping Hu; Ganghua Tang
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

Review 7.  PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.

Authors:  Koen Mertens; Dominique Slaets; Bieke Lambert; Marjan Acou; Filip De Vos; Ingeborg Goethals
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-11       Impact factor: 9.236

8.  Diagnostic accuracy of ¹¹C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma.

Authors:  Egesta Lopci; Guido Torzilli; Dario Poretti; Lauro J Souza de Neto; Matteo Donadon; Lorenza Rimassa; Ezio Lanza; Juliano Guerra Sabongi; Roberto Ceriani; Nicola Personeni; Angela Palmisano; Vittorio Pedicini; Tiziana Comito; Marta Scorsetti; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-05-12       Impact factor: 9.236

9.  [(Methyl)1-(11)c]-acetate metabolism in hepatocellular carcinoma.

Authors:  Nicolas Salem; Yu Kuang; David Corn; Bernadette Erokwu; Jeffrey A Kolthammer; Haibin Tian; Chunying Wu; Fangjing Wang; Yanming Wang; Zhenghong Lee
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

10.  [18F]-choline PET/CT as an imaging biomarker for primary liver cancers.

Authors:  Zhenghong Lee
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.